ArticleIndian journal of ophthalmology2022
Analysis of COVID-19 publications in the
Article in Indian journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Trends in Research on Patients With COVID-19 in Korean Medical Journals.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2024Article
- Commentary: Impact of social media applications like Instagram, Facebook, Twitter, and YouTube on ophthalmological education.Indian journal of ophthalmology · 2022Article
- The renaissance of questionnaire-based studies in the wake of COVID-19.Indian journal of ophthalmology · 2022Article
- Renaissance of scholarly and academic profiles during COVID-19 pandemic.Indian journal of ophthalmology · 2022Article
- Renaissance of a new era of ophthalmology residency training: Silver linings after three waves of COVID-19.Indian journal of ophthalmology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To perform a comprehensive analysis of COVID-19 publications published in the Indian Journal of Ophthalmology (IJO) during the two years of the pandemic and to study their impact on ophthalmic literature. Methods: : A retrospective analysis was performed of all expedited COVID-19 articles published in IJO from April 2020 to March 2022. The data was obtained from the official website of IJO, editor IJO monthly emails, and PubMed database. The data was then extracted as XML into Microsoft Access for scientometric analysis. The expedited articles were segregated into different categories: original, review, case report/series, letter to the editor, commentary, current ophthalmology, consensus criteria, perspective, innovations, ophthalmic images, photoessays, research methodology, and surgical techniques. The monthly data was analyzed and COVID-19 articles were assessed for subspecialty-wise distribution, number of citations, monthly growth rate, and their impact on ophthalmic literature. Results: A total of 431 COVID-19 related articles were published during the study period. The majority of the articles were letters to the editor (158, 36.65%) followed by original articles (97, 22.50%), and commentaries (53, 12.29%). The least were perspectives and ophthalmic images (2, 0.46%) each followed by consensus criteria (1, 0.23%). The maximum publications came in July 2020 (44, 10.20%) followed by December 2021 (37, 8.58%) and October 2021 (36, 8.35%), and the least were in April 2020 (1, 0.23%). Considering subspecialty, a majority of the articles were related to general ophthalmology (156, 36.19%), and the least was in oncology (2, 0.46%). The maximum number of citations were attracted by original articles (97, 1146 (11.81)), which were approximately 1.5 times higher than the letters to the editor (158, 743 (4.70)) and 3 times higher than review articles (9, 387 (43)). Among specialties, the maximum number of citations were gathered by general ophthalmology (156, 1320 (8.46)) followed by oculoplasty (36, 592 (16.44)) due to the concurrent mucormycosis epidemic. Conclusion: : IJO opened a window of opportunity for authors by publishing quality expedited articles. Evidence-based orbital mucormycosis and general ophthalmology publications gathered most of the attention due to their heterogeneous presentation. The peak of the first wave (June-July 2020) and the October and December 2021 issues had maximum number of COVID-19 articles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.